1887

Journal of General Virology header logo

Volume 92, Issue 11

Disruption of repressive p130–DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells Free

Abstract

Human papillomaviruses (HPVs) with tropism for mucosal epithelia are the major aetiological factors in cervical cancer. Most cancers are associated with so-called high-risk HPV types, in particular HPV16, and constitutive expression of the HPV16 E6 and E7 oncoproteins is critical for malignant transformation in infected keratinocytes. E6 and E7 bind to and inactivate the cellular tumour suppressors p53 and Rb, respectively, thus delaying differentiation and inducing proliferation in suprabasal keratinocytes to enable HPV replication. One member of the Rb family, p130, appears to be a particularly important target for E7 in promoting S-phase entry. Recent evidence indicates that p130 regulates cell-cycle progression as part of a large protein complex termed DREAM. The composition of DREAM is cell cycle-regulated, associating with E2F4 and p130 in G0/G1 and with the B-myb transcription factor in S/G2. In this study, we addressed whether p130–DREAM is disrupted in HPV16-transformed cervical cancer cells and whether this is a critical function for E6/E7. We found that p130–DREAM was greatly diminished in HPV16-transformed cervical carcinoma cells (CaSki and SiHa) compared with control cell lines; however, when E6/E7 expression was targeted by specific small hairpin RNAs, p130–DREAM was reformed and the cell cycle was arrested. We further demonstrated that the profound G1 arrest in E7-depleted CaSki cells was dependent on p130–DREAM reformation by also targeting the expression of the DREAM component Lin-54 and p130. The results show that continued HPV16 E6/E7 expression is necessary in cervical cancer cells to prevent cell-cycle arrest by a repressive p130–DREAM complex.

  • Received:
  • Accepted:
  • Published Online:
© 2011 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.035352-0
2011-11-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/11/2620.html?itemId=/content/journal/jgv/10.1099/vir.0.035352-0&mimeType=html&fmt=ahah

References

  1. Cheng L., Rossi F., Fang W., Mori T., Cobrinik D. 2000; Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(−), p16INK4A(+) tumor cells. J Biol Chem 275:30317–30325 [View Article][PubMed]
     [Google Scholar]
  2. Cobrinik D. 2005; Pocket proteins and cell cycle control. Oncogene 24:2796–2809 [View Article][PubMed]
     [Google Scholar]
  3. Doorbar J. 2006; Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110:525–541 [View Article][PubMed]
     [Google Scholar]
  4. Genovese N. J., Banerjee N. S., Broker T. R., Chow L. T. 2008; Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol 82:4862–4873 [View Article][PubMed]
     [Google Scholar]
  5. Hall A. H. S., Alexander K. A. 2003; RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77:6066–6069 [View Article][PubMed]
     [Google Scholar]
  6. Harrison M. M., Ceol C. J., Lu X., Horvitz H. R. 2006; Some C. elegans class B synthetic multivulva proteins encode a conserved LIN-35 Rb-containing complex distinct from a NuRD-like complex. Proc Natl Acad Sci U S A 103:16782–16787 [View Article][PubMed]
     [Google Scholar]
  7. Jiang M., Milner J. 2002; Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21:6041–6048 [View Article][PubMed]
     [Google Scholar]
  8. Johung K., Goodwin E. C., DiMaio D. 2007; Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 81:2102–2116 [View Article][PubMed]
     [Google Scholar]
  9. Knight A. S., Notaridou M., Watson R. J. 2009; A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells. Oncogene 28:1737–1747 [View Article][PubMed]
     [Google Scholar]
  10. Korenjak M., Taylor-Harding B., Binné U. K., Satterlee J. S., Stevaux O., Aasland R., White-Cooper H., Dyson N., Brehm A. 2004; Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119:181–193 [View Article][PubMed]
     [Google Scholar]
  11. Lam E. W., Watson R. J. 1993; An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12:2705–2713[PubMed]
     [Google Scholar]
  12. Lam E. W., Morris J. D., Davies R., Crook T., Watson R. J., Vousden K. H. 1994; HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J 13:871–878[PubMed]
     [Google Scholar]
  13. Lewis P. W., Beall E. L., Fleischer T. C., Georlette D., Link A. J., Botchan M. R. 2004; Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev 18:2929–2940 [View Article][PubMed]
     [Google Scholar]
  14. Litovchick L., Sadasivam S., Florens L., Zhu X., Swanson S. K., Velmurugan S., Chen R., Washburn M. P., Liu X. S., DeCaprio J. A. 2007; Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26:539–551 [View Article][PubMed]
     [Google Scholar]
  15. McLaughlin-Drubin M. E., Münger K. 2009; Oncogenic activities of human papillomaviruses. Virus Res 143:195–208 [View Article][PubMed]
     [Google Scholar]
  16. Osterloh L., von Eyss B., Schmit F., Rein L., Hübner D., Samans B., Hauser S., Gaubatz S. 2007; The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis. EMBO J 26:144–157 [View Article][PubMed]
     [Google Scholar]
  17. Pilkinton M., Sandoval R., Colamonici O. R. 2007; Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex. Oncogene 26:7535–7543 [View Article][PubMed]
     [Google Scholar]
  18. Popov B., Chang L. S., Serikov V. 2005; Cell cycle-related transformation of the E2F4-p130 repressor complex. Biochem Biophys Res Commun 336:762–769 [View Article][PubMed]
     [Google Scholar]
  19. Rampias T., Sasaki C., Weinberger P., Psyrri A. 2009; E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 101:412–423 [View Article][PubMed]
     [Google Scholar]
  20. Saville M. K., Watson R. J. 1998; The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene 17:2679–2689 [View Article][PubMed]
     [Google Scholar]
  21. Schmit F., Korenjak M., Mannefeld M., Schmitt K., Franke C., von Eyss B., Gagrica S., Hänel F., Brehm A., Gaubatz S. 2007; LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes. Cell Cycle 6:1903–1913 [View Article][PubMed]
     [Google Scholar]
  22. Sima N., Wang W., Kong D., Deng D., Xu Q., Zhou J., Xu G., Meng L., Lu Y. et al. 2008; RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis 13:273–281 [View Article][PubMed]
     [Google Scholar]
  23. Tang S., Tao M., McCoy J. P. Jr, Zheng Z. M. 2006; Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene 25:2094–2104 [View Article][PubMed]
     [Google Scholar]
  24. Tavner F., Frampton J., Watson R. J. 2007; Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Oncogene 26:2727–2735 [View Article][PubMed]
     [Google Scholar]
  25. Tschöp K., Conery A. R., Litovchick L., Decaprio J. A., Settleman J., Harlow E., Dyson N. 2011; A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 25:814–830 [View Article][PubMed]
     [Google Scholar]
  26. Yamato K., Yamada T., Kizaki M., Ui-Tei K., Natori Y., Fujino M., Nishihara T., Ikeda Y., Nasu Y. et al. 2008; New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 15:140–153 [View Article][PubMed]
     [Google Scholar]
  27. Yugawa T., Kiyono T. 2009; Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19:97–113 [CrossRef]
     [Google Scholar]
  28. Zhang B., Chen W., Roman A. 2006; The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A 103:437–442 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.035352-0
Loading
Disruption of repressive p130–DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells
J. Gen. Virol. 92, 2620 (2011); https://doi.org/10.1099/vir.0.035352-0
/content/journal/jgv/10.1099/vir.0.035352-0
/content/journal/jgv/10.1099/vir.0.035352-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error